Novo Nordisk to Introduce Ozempic in India This Month
Danish pharmaceutical giant Novo Nordisk (NOVOb.CO) is preparing to roll out its diabetes medication Ozempic in India within the next…
Danish pharmaceutical giant Novo Nordisk (NOVOb.CO) is preparing to roll out its diabetes medication Ozempic in India within the next…
Eli Lilly and Company has announced a definitive agreement to acquire Adverum Biotechnologies, Inc., a clinical-stage biotechnology firm specializing in…
Eli Lilly and Company has unveiled an ambitious plan to invest more than USD 1 billion in new contract manufacturing…
US pharma giant Eli Lilly is preparing to expand its footprint in India’s fast-growing weight-loss drug market. After launching its…
Overweight and obesity are becoming more and more common in India, affecting not only adults but also youngsters. The regional…
Eli Lilly and Company (India) has announced a strategic partnership with Apollo Health and Lifestyle and Apollo HealthCo both part…
Global pharmaceutical company Lupin has announced the acquisition of the Huminsulin brand in India from Eli Lilly and Company. This…
Eli Lilly’s Mounjaro has emerged as the leading choice in the UK’s private obesity drug market, outperforming Novo Nordisk’s Wegovy…
Eli Lilly, the U.S.-based pharmaceutical giant, plans to introduce its obesity and diabetes drug Tirzepatide (marketed as Mounjaro) in India…
Novo Nordisk’s team in India is asking the company’s global leaders to launch its weight-loss drug Wegovy earlier than planned….